APS development strategy is to explore innovative targeted anti-tumor drugs and develop the latest generation of novel targeted anti-tumor drugs with APS unique platform. APS focus on drug resistance and tumor metastasis to develop next-generation breakthrough cancer therapies.
APS seeking cooperation opportunities with worldwide biomedical research institutions, companies and professional scientists during all stages of the drug development including the discovery stage, clinical stage and global commercialization stage through flexible co-development, license-out and license-in cooperation models. APS is Looking forward to exploring frontier technology and innovating cancer breakthrough therapies and improving the human health with partners all over the world.
Office: Philadelphia, US
Office: Building 10-1, No.2 Jingyuan North Street, BDA, Beijing, China